在癌症进展中,lncRNA和免疫检查点之间的协同关系的动态变化
Chenyu Liu1, Qianyi Lu1, Jian Li1
1College of Bioinformatics Science and Technology, Harbin Medical University, No. 157, Baojian Road, Nangang District, Harbin City, Heilongjiang Province, China.
Briefings in bioinformatics
|July 29, 2025
概括
长非编码RNAs (lncRNAs) 和免疫检查点 (ICPs) 协同相互作用,推动癌症的进展. 识别这些协同作用的lncRNA-ICP对揭示了患者生存和免疫治疗反应的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 通过免疫检查点 (ICP) 进行免疫逃避对瘤进展至关重要.
- 长非编码RNAs (lncRNAs) 在癌症和免疫中的作用已经确立,但它们与ICPs的相互作用尚不清楚.
研究的目的:
- 研究 lncRNAs 和 ICPs 在癌症进展中的协同关系.
- 为了确定特定阶段的lncRNA-ICP对及其与癌症特征的关联.
主要方法:
- 综合手工策划的ICPs和使用蛋白质-蛋白质相互作用网络的lncRNA-mRNA相互作用.
- 计算了特定阶段的协同效应得分,以确定跨癌症类型的关键lncRNA-ICP对.
- 使用空间转录组学数据和生存分析验证的发现.
主要成果:
- 确定了许多特定阶段的协同作用的lncRNA-ICP对,其中经常涉及MALAT1和CRNDE.
- lncRNA-ICP网络基因与癌症进展期间的免疫细胞动态相关,显示跨癌症稳定性.
- 第4阶段识别的基因显著预测了患者的存活率和免疫治疗反应.
结论:
- lncRNA-ICP协同网络提供了有关癌症免疫逃避机制的见解.
- 特定的lncRNA-ICP对作为预测癌症患者结果和治疗疗效的潜在生物标志物.
相关概念视频
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


